Discover how generic drugs are manufactured, from reverse engineering brand-name formulas to rigorous bioequivalence testing and CGMP compliance. Learn why generics are safe, effective, and significantly cheaper.
Explore how pharmaceutical companies use evergreening strategies to delay generic competition, keeping drug prices high. Learn about patent thickets, product hopping, and the impact on patient access.
Discover how your genetics and family history influence your response to generic drugs. Learn about pharmacogenetics, key genes like CYP2D6, and tips for managing medication transitions safely.
Generic drugs can save you money-but not all generics are cheap. Some cost 15 times more than equally effective alternatives. Learn how combination drugs and smart substitutions can cut your prescription costs by up to 90%.
Generic drugs save billions but face stubborn perception gaps. Learn how new transparency tools, provider education, and biosimilars are changing how patients and providers view these proven, affordable medications.
Understanding how generic drugs maintain safety and potency over time through stability testing, storage conditions, and regulatory standards - and why expiration dates matter more than you think.
Learn how community health presentations are helping people understand that generic drugs are just as safe and effective as brand-name medicines-while saving billions in healthcare costs.
Pharmaceutical prices vary dramatically across countries due to policy differences. The U.S. has high list prices but low generic costs, while countries like Japan and France use negotiation and price caps to keep costs down. Medicare's new negotiation power is changing the landscape.
Generics make up 90% of prescriptions but only 25% of drug spending - yet they drive nearly all pharmacy profits. Here’s how the broken economics of PBMs, spreads, and clawbacks are reshaping who wins and who loses in the drug supply chain.
The FDA approves generic drugs through the ANDA process, ensuring they're as safe and effective as brand-name drugs without repeating costly clinical trials. Learn how bioequivalence, manufacturing standards, and regulatory timelines make generics affordable and reliable.